Detalhe da pesquisa
1.
Comparing Molnupiravir to Nirmatrelvir/Ritonavir (Paxlovid) in the Treatment of Mild-to-Moderate COVID-19 in Immunocompromised Cancer Patients.
Cancers (Basel)
; 16(5)2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38473412